NCT06033976

Brief Summary

This is a patient registry for all cases of pre-neoplastic or early neoplastic digestive tract lesions treated with curative intention by endoscopic submucosal dissection (ESD) technique.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
57mo left

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Jan 2021Jan 2031

Study Start

First participant enrolled

January 1, 2021

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 3, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2031

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2031

Last Updated

November 12, 2024

Status Verified

November 1, 2024

Enrollment Period

10 years

First QC Date

September 3, 2023

Last Update Submit

November 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of curative resection

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Rate of R0 resection

    through study completion, an average of 1 year

Other Outcomes (2)

  • Rate of perforation

    30 days

  • Rate of delayed bleeding

    30 days

Interventions

Endoscopic injection of fluid into the gastrointestinal submucosal space followed by endoscopic knife dissection around and under the lesion so as to remove the lesion specimen in one piece with lesion free resection margins.

Also known as: ESD

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed at or referred to Gastroenterology Clinic, University of Medicine and Pharmacy, "Agrippa Ionescu" Hospital, Bucharest, Romania

You may qualify if:

  • epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal, gastric, duodenal or colorectal mucosa
  • non-epithelial (eg. neuroendocrine tumor) lesion on the esophageal, gastric, duodenal or colorectal mucosa
  • age \> 18 years old
  • informed consent

You may not qualify if:

  • age \< 18 years old
  • no informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

"Agrippa Ionescu" Hospital

Bucharest, Romania

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Resected specimens of the gastrointestinal tract, fixed in formalin

MeSH Terms

Conditions

Stomach NeoplasmsColorectal NeoplasmsEsophageal NeoplasmsDuodenal Neoplasms

Interventions

Endoscopic Mucosal Resection

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesIntestinal NeoplasmsColonic DiseasesIntestinal DiseasesRectal DiseasesHead and Neck NeoplasmsEsophageal DiseasesDuodenal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Mihai L Ciocirlan, Associate Professor

    Carol Davila University of Medicine and Pharmacy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ciocirlan L Mihai, Associate Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor (Associate Professor)

Study Record Dates

First Submitted

September 3, 2023

First Posted

September 13, 2023

Study Start

January 1, 2021

Primary Completion (Estimated)

January 1, 2031

Study Completion (Estimated)

January 1, 2031

Last Updated

November 12, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations